Mesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferation

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Sassoli, Chiara ^a   Frati, Alessia ^b   Tani, Alessia ^a   Anderloni, Giulia ^b   Pierucci, Federica ^b   Matteini, Francesca ^b   Chellini, Flaminia ^a   Orlandini, Sandra Zecchi ^a   Formigli, Lucia ^c   Meacci, Elisabetta ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE INHIBITOR; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; CULTURE MEDIUM; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL ANALYSIS; C2C12 CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CELLULAR SECRETION; CONTROLLED STUDY; CULTURE MEDIUM; MALE; MESENCHYMAL STROMA CELL; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; SATELLITE CELL; YOUNG ADULT; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; CELL CULTURE; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; REGENERATION; SECRETION (PROCESS); SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; LYSOPHOSPHOLIPIDS; MESENCHYMAL STROMAL CELLS; MICE; MYOBLASTS, SKELETAL; PARACRINE COMMUNICATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REGENERATION; SIGNAL TRANSDUCTION; SPHINGOSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84938721329     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108662     Document Type: Article

References (63)

1. Pretheeban T, Lemos DR, Paylor B, Zhang RH, Rossi FM (2012) Role of stem/progenitor cells in reparative disorders. Fibrogenesis Tissue Repair 5: 20. doi:10.1186/1755-1536-5-20.
2. Sassoli C, Zecchi-Orlandini S, Formigli L (2012) Trophic Actions of Bone Marrow-Derived Mesenchymal Stromal Cells for Muscle Repair/Regeneration. Cells 1: 832-850. doi:10.3390/cells1040832.
3. Das M, Sundell IB, Koka PS (2013) Adult mesenchymal stem cells and their potency in the cell-based therapy. J Stem Cells 8: 1-16.
4. Formigli L, Paternostro F, Tani A, Mirabella C, Quattrini Li A, et al. (2013) Bioengineered Mesenchymal stromal cell (MSCs) grafts for skin repair/regeneration, Preclinical aspects. J Regen Med 2:1 http://dx.doi.org/10.4172/2325-9620.1000106.
5. Pileggi A, Xu X, Tan J, Ricordi C (2013) Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials. Curr Opin Organ Transplant 18: 672-681. doi:10.1097/MOT.0000000000000029.
6. Aoyama T, Goto K, Kakinoki R, Ikeguchi R, Ueda M, et al. (2014) An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng Part B Rev, in press.
7. Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S, et al. (2004) Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibres. Tissue Eng 10: 1093-1112.
8. de la Garza-Rodea AS, van der Velde I, Boersma H, Gonçalves MA, van Bekkum DW, et al. (2011) Long-term contribution of human bone marrow mesenchymal stromal cells to skeletal muscle regeneration in mice. Cell Transplant 20: 217-231. doi:10.3727/096368910X522117.
9. von Roth P, Duda GN, Radojewski P, Preininger B, Perka C, et al. (2012) Mesenchymal stem cell therapy following muscle trauma leads to improved muscular regeneration in both male and female rats. Gend Med 9: 129-136. doi:10.1016/j.genm.2012.01.007.
10. Kanemaru S, Kitani Y, Ohno S, Shigemoto T, Kojima T, et al. (2013) Functional regeneration of laryngeal muscle using bone marrow-derived stromal cells. Laryngoscope 123: 2728-34. doi:10.1002/lary.24060.
11. Winkler T, von Roth P, Radojewski P, Urbanski A, Hahn S, et al. (2012) Immediate and delayed transplantation of mesenchymal stem cells improve muscle force after skeletal muscle injury in rats. J Tissue Eng Regen Med 6:s60- s67. doi:10.1002/term.1542.
12. Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, et al. (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309: 314-317.
13. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
14. Hoffmann J, Glassford AJ, Doyle TC, Robbins RC, Schrepfer S, et al. (2010) Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia. Thorac Cardiovasc Surg 58: 136- 142. doi:10.1055/s-0029-1240758.
15. Li Z, Liu HY, Lei QF, Zhang C, Li SN (2011) Improved motor function in dko mice by intravenous transplantation of bone marrow-derived mesenchymal stromal cells. Cytotherapy 13: 69-77. doi:10.3109/14653249.2010.510502.
16. Nitahara-Kasahara Y, Hayashita-Kinoh H, Ohshima-Hosoyama S, Okada H, Wada-Maeda M, et al. (2012) Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy. Mol Ther 20: 168-177. doi:10.1038/mt.2011.181.
17. Shabbir A, Zisa D, Leiker M, Johnston C, Lin H, et al. (2009) Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation. Transplantation 87: 1275- 1282. doi:10.1097/TP.0b013e3181a1719b.
18. Lee RH, Oh JY, Choi H, Bazhanov N (2011) Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem 112: 3073-3078. doi:10.1002/jcb.23250.
19. Sassoli C, Nosi D, Tani A, Chellini F, Mazzanti B, et al. (2014) Defining the role of mesenchymal stromal cells on the regulation of matrix metalloproteinases in skeletal muscle cells. Exp Cell Res 323: 297-313. doi:10.1016/j.yexcr.2014.03.003.
20. Sassoli C, Pini A, Chellini F, Mazzanti B, Nistri S, et al. (2012) Bone Marrow Mesenchymal Stromal Cells Stimulate Skeletal Myoblast Proliferation through the Paracrine Release of VEGF. PLoS One 7 e37512. doi:10.1371/journal.-pone.0037512.
21. Bassi R, Anelli V, Giussani P, Tettamanti G, Viani P, et al. (2006) Sphingosine 1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi protein- coupled receptors. Glia 53: 621-630.
22. Kim RH, Takabe K, Milstien S, Spiegel S (2009) Export and functions of sphingosine-1-phosphate. Biochim Biophys Acta 1791: 692-696. doi:10.1016/j.bbalip.2009.02.011.
23. Riccitelli E, Giussani P, Di Vito C, Condomitti G, Tringali C, et al. (2013) Extracellular sphingosine-1-phosphate: A novel actor in human glioblastoma stem cell survival. PLoS One 8(6):e68229. doi:10.1371/journal.pone.0068229.
24. O'Sullivan C, Dev KK (2013) The structure and function of the S1P1 receptor. Trends Pharmacol Sci 34: 401-412. doi:10.1016/j.tips.2013.05.002.
25. Bencini C, Squecco R, Piperio C, Formigli L, Meacci E, et al. (2003) Effects of sphingosine 1-phosphate on excitation-contraction coupling in mammalian skeletal muscle. J Muscle Res Cell Motil 24: 539-554.
26. Squecco R, Sassoli C, Nuti F, Martinesi M, Chellini F, et al. (2006) Sphingosine 1-phosphate induces myoblast differentiation through Cx43 protein expression: A role for a gap junction-dependent and -independent function.Mol Biol Cell 17: 4896-4910.
27. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signaling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150. doi:10.1038/nrm2329.
28. Formigli L, Sassoli C, Squecco R, Bini F, Martinesi M, et al. (2009) Regulation of transient receptor potential canonical channel 1 (TRPC1) by sphingosine 1- phosphate in C2C12 myoblasts and its relevance for a role of mechanotransduction in skeletal muscle differentiation. J Cell Sci 122: 1322-1333. doi:10.1242/jcs.035402.
29. Meacci E, Bini F, Sassoli C, Martinesi M, Squecco R, et al. (2010) Functional interaction between TRPC1 channel and connexin-43 protein: A novel pathway underlying S1P action on skeletal myogenesis. Cell Mol Life Sci 67: 4269-4285. doi:10.1007/s00018-010-0442-3.
30. Nikolova-Karakashian MN, Reid MB (2011) Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle. Antioxid Redox Signal 15: 2501-2517. doi:10.1089/ars.2011.3940.
31. Sassoli C, Formigli L, Bini F, Tani A, Squecco R, et al. (2011) Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction. J Cell Mol Med 15: 2498-2511. doi:10.1111/j.1582-4934.2010.01250.x.
32. Meacci E, Bini F, Battistini C (2012) Sphingosine-1-phosphate signaling in skeletal muscle cells. Methods Mol Biol 874: 155-165. doi:10.1007/978-1-61779-800-9-12.
33. Mendelson K, Evans T, Hla T (2014) Sphingosine 1-phosphate signalling. Development 141: 5-9. doi:10.1242/dev.094805.
34. Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T (2003) VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci U S A 100: 10664-10669.
35. Balthasar S, Bergelin N, Lö f C, Vainio M, Andersson S, et al. (2008) Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. Endocr Relat Cancer 15: 521-534. doi:10.1677/ERC-07-0253.
36. Ryu JM, Baek YB, Shin MS, Park JH, Park SH, et al. (2014) Sphingosine-1- phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent b-arrestin/c-Src pathways. Stem Cell Res 12: 69-85. doi:10.1016/j.scr.2013.08.013.
37. Dobson KR, Reading L, Haberey M, Marine X, Scutt A (1999) Centrifugal isolation of bone marrow from bone: An improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int 65: 411-413.
38. Meacci E, Nuti F, Donati C, Cencetti F, Farnararo M, et al. (2008) Sphingosine kinase activity is required for myogenic differentiation of C2C12 myoblasts. J Cell Physiol 14: 210-220.
39. Kobayashi NI, Kobayashi N, Yamaguchi A, Nishi T (2009) Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem 284: 21192-21200. doi:10.1093/jxb/ers344.
40. Yatomi Y, Ohmori T, Rile G, Kazama F, Okamoto H, et al. (2000) Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 96: 3431-3438.
41. Bini F, Frati A, Garcia-Gil M, Battistini C, Granado M, et al. (2012) New signalling pathway involved in the anti-proliferative action of vitamin D3 and its analogues in human neuroblastoma cells. A role for ceramide kinase. Neuropharmacology 63: 524-537doi:10.1016/j.neuropharm.2012.04.026.
42. Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1- phosphate signaling and its role in disease. Trends Cell Biol 22: 50-60. doi:10.1016/j.tcb.2011.09.003.
43. Donati C, Meacci E, Nuti F, Becciolini L, Farnararo M, et al. (2005) Sphingosine 1-phosphate regulates myogenic differentiation: A major role for S1P2 receptor. FASEB J 19: 449-451.
44. Brooks NE, Myburgh KH (2014) Skeletal muscle wasting with disuse atrophy is multi-dimensional: The response and interaction of myonuclei, satellite cells and signaling pathways. Front Physiol 5:99. doi:10.3389/fphys.2014.00099.
45. Tidball JG, Villalta SA (2010) Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 298: R1173-R1187. doi:10.1152/ajpregu.00735.2009.
46. Ten Broek RW, Grefte S, Von den Hoff JW (2010) Regulatory factors and cell populations involved in skeletal muscle regeneration. J Cell Physiol 224: 7-16. doi:10.1002/jcp.22127.
47. Carosio S, Berardinelli MG, Aucello M, Musarò A (2011) Impact of ageing on muscle cell regeneration. Ageing Res Rev 10: 35-42. doi:10.1016/j.arr.2009.08.001.
48. Huang YC, Dennis RG, Baar K (2006) Cultured slow vs. fast skeletal muscle cells differ in physiology and responsiveness to stimulation. Am J Physiol Cell Physiol 291: C11-C17.
49. Biressi S, Rando TA (2010) Heterogeneity in the muscle satellite cell population. Semin Cell Dev Biol 21: 845-854. doi:10.1016/j.semcdb.2010.09.003.
50. Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, et al. (2005) Direct isolation of satellite cells for skeletal muscle regeneration. Science 309: 2064- 2067.
51. Sammels LM, Bosio E, Fragall CT, Grounds MD, van Rooijen N, et al. (2004) Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 77: 1790-1797.
52. Price FD, Kuroda K, Rudnicki MA (2007) Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Act 1772: 272-283.
53. Loh KC, Leong WI, Carlson ME, Oskouian B, Kumar A, et al. (2012) Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. PLoS One 7(5):e37218. doi:10.1371/journal.pone.0037218.
54. Fortier M, Figeac N, White RB, Knopp P, Zammit PS (2013) Sphingosine-1- phosphate receptor 3 influences cell cycle progression in muscle satellite cells. Dev Biol 382: 504-516. doi:10.1016/j.ydbio.2013.07.006.
55. de la Garza-Rodea AS, Baldwin DM, Oskouian B, Place RF, Bandhuvula P, et al. (2014) Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression. FASEB J 28: 506-519. doi:10.1096/fj.13-233155.
56. Danieli-Betto D, Germinario E, Esposito A, Megighian A, Midrio M, et al. (2005) Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. Am J Physiol Cell Physiol 288: C1367-C1373.
57. Danieli-Betto D, Peron S, Germinario E, Zanin M, Sorci G, et al. (2010) Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration. Am J Physiol Cell Physiol 298: C550-C558. doi:10.1152/ajpcell.00072.2009.
58. Tanimoto T, Jin ZG, Berk BC (2002) Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1- phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277: 42997-43001.
59. Shu X, Wu W, Mosteller RD, Broek D (2002) Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogenactivated protein kinases. Mol Cell Biol 22: 7758-7768.
60. Bergelin N, Löf C, Balthasar S, Kalhori V, Törnquist K (2010) S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration. Endocrinology 151: 2994-3005. doi:10.1210//en.2009-1387.
61. Li MH, Hla T, Ferrer F (2011) Sphingolipid modulation of angiogenic factor expression in neuroblastoma. Cancer Prev Res (Phila) 4: 1325-1332. doi:10.1158/1940-6207.CAPR-11-0017.
62. Huang WC, Nagahashi M, Terracina KP, Takabe K (2013) Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis 3(3). doi:10.3390/biom3030408.
63. Fieber CB, Eldridge J, Taha TA, Obeid LM, Muise-Helmericks RC (2006) Modulation of total Akt kinase by increased expression of a single isoform: Requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells. Experimental Cell Research 312: 1164-1173.